Table. 6.

Distribution of instruments and mean, SD, and CVs (%) for glucose point-of-care testing (GGP-19-04 to GGP-19-06)

Manufacturer Instrument group No. GGP-19-04 GGP-19-05 GGP-19-06



Mean±SD CV (%) Mean±SD CV (%) Mean±SD CV (%)
Abbott Freestyle Optimum 22 157.9±6.8 4.3 321.7±9.9 3.1 82.7±4.3 5.2
Freestyle Optimum Neo 31 156.3±13.8 8.8 329.3±31.8 9.6 73.0±4.7 6.4
Freestyle Optimum Neo H 8
Freestyle Optimum Xceed 19 153.6±5.2 3.4 296.1±20.6 7.0 77.3±4.2 5.5
Allmedicus GlucoDr. Auto (AGM-4000) 10 102.1±4.7 4.6 37.9±4.4 11.7
GlucoDr. Plus (AGM-3000/B) 15 116.4±6.4 5.5 315.5±43.0 13.6 50.5±16.3 32.4
GlucoDr. (AGM-2100)
Others 41 105.4±5.0 4.8 270.1±22.4 8.3 41.5±2.8 6.6
Arkray Inc. Glucocard 01 10 86.4±2.3 2.6 266.4±4.6 1.7 37.5±1.0 2.6
Glucocard Ⅱ 1
Ascensia Breeze 2
Contour plus 62 117.8±3.2 2.7 272.0±7.7 2.8 59.0±1.5 2.5
Contour T
GC Medis Green check 26 108.5±5.6 5.2 254.0±5.8 2.3 33.8±2.3 6.7
Others 4
Infopia Gluneo Lite
Gluneo Plus 190 109.7±10.4 9.5 258.3±22.7 8.8 64.4±6.3 9.8
GlucoLAB Auto-coding 22 108.8±2.4 2.2 257.5±18.8 7.3 62.0±1.6 2.6
Mirae 3.3G+ 5
GlucoLAB
Others
i-SENS ACURA plus 52 107.1±6.4 6.0 282.7±23.6 8.3 43.0±4.5 10.5
BAROZen 61 104.3±9.3 9.0 239.0±44.1 18.4 42.9±3.1 7.2
BAROZen H 59 103.1±5.2 2.0 293.1±11.4 3.9 41.4±2.9 6.9
BAROzen H expert 396 136.6±10.1 7.4 395.7±27.8 7.0 54.4±2.8 5.2
BAROzen H expert plus 321 136.2±11.1 8.2 388.8±25.7 6.6 54.6±2.5 4.5
BAROZen H plus 154 129.6±19.4 15.0 379.5±69.4 18.3 53.7±3.6 6.7
BAROZen II 14 108.2±2.0 1.9 287.9±10.3 3.6 44.6±1.9 4.2
BAROZen plus 134 109.7±6.7 6.1 268.4±8.8 3.3 55.9±3.0 5.3
CareSens Dual 10 59.9±2.8 4.7 136.8±4.4 3.2 400.1±4.8 1.2
CareSens II 1
CareSens N 60 106.2±6.1 5.7 298.2±18.1 6.1 44.5±2.0 4.5
CareSens N Voice 97 105.7±4.2 3.9 292.2±13.3 4.5 43.6±2.9 6.6
CareSens PRO 104 138.3±6.9 5.0 431.5±30.0 6.9 54.1±3.3 6.1
others
Philosys Gmate check 46 121.0±12.6 10.4 328.9±34.0 10.3 50.4±5.2 10.3
Gmate Origin 26 112.7±3.7 3.3 315.9±6.0 1.9 46.8±1.9 4.2
Gmate WHeeL 11 101.5±1.0 1.0 284.6±1.9 0.7 44.0±0.9 2.0
Roche Accu-Check Active 153 189.3±13.6 7.2 447.2±20.2 4.5 93.7±8.9 9.5
Accu-Check Inform II 461 185.9±21.8 11.7 441.4±62.0 14.1 76.6±4.5 5.9
Accu-Check Performa 722 169.3±7.5 4.0 405.8±10.9 2.7 75.1±4.6 6.2
Others 14 999.0±0.0 0.0 999.0±0.0 0.0 999.0±0.0 0.0
SD Biosensor SD CHECK GOLD (Meter 01GM10) 38 103.6±39.3 37.9 249.0±119.6 48.0 210.3±143.0 68.0
SD CHECK GOLD (System 01GC12)
SD CodeFree (Meter 01GM11) 134 146.0±7.1 4.9 364.5±14.3 39 69.9±5.1 7.4
SD CodeFree (System 01GC112) 8
SD GlucoNavii
SD GlucoNavii GDH (Meter 01GM30) 49 62.4±7.1 11.4 124.4±12.6 10.1 292.0±17.2 5.9
SD GlucoNavii GDH (System 01GC32) 19 147.1±5.5 3.7 346.2±23.2 6.7 63.8±4.0 6.3
SD GlucoNavii Link 0.3 (Meter 01GM12) 41 133.6±8.5 6.4 215.6±113.7 52.7 36.6±22.7 621
SD GlucoNavii Link 0.3 (System 01GC122)
SD GlucoNavii NFC (Meter 01GM40) 65 1,413±52 3.7 338.9±27.6 8.1 66.6±8.2 12.3
SD GlucoNavii NFC (System 01GC42)
Wise Meditech Wisecheck 13 119.5±0.9 0.8 335.7±4.0 1.2 44.4±0.5 1.1
Others Others 74 90.7±22.9 25.3 226.5±58.0 25.6 37.7±6.9 18.2

The instruments used were from the following companies: Abbott (Abbott Park, IL, USA), Allmedicus (Anyang, Korea), Arkray Inc. (St. Edina, MN, USA), Ascensia (Newbury, UK), GC Medis (Cheonan, Korea), Infopia (Anyang, Korea), i-SENS (Seoul, Korea), Philosys (Gunsan, Korea), Roche (Indianapolis, IN, USA), SD Biosensor (Suwon, Korea), and Wise Meditech (Anyang, Korea).

Abbreviation: SD, standard deviation; CV, coefficient of variance.

Lab Med Qual Assur 2021;43:43~55 https://doi.org/10.15263/jlmqa.2021.43.2.43
© Lab Med Qual Assur